Institutional Perspectives on Assisted Reproductive Technology Using Third‐Party Gametes in Japan: A Nationwide Survey of Assisted Reproductive Technology Facilities
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 25 (1)
Abstract
Objective: To clarify institutional perspectives on assisted reproductive technology (ART) using third‐party gametes. Methods: We surveyed 634 facilities registered with the Japan Society of Obstetrics and Gynecology, and 416 responses were included in a descriptive analysis. Results: Psychosocial and economic stability of ART recipient couples were considered necessary in most facilities (94.6%). Japanese nationality and legal marriage were necessary recipient criteria in 36.8% and 54.3% facilities, respectively. Lower and upper age limits for female recipients were 20–25 and 43–45 years, respectively, whereas most male partners had no upper age limit (34.6%–36.6%). The most common upper age limit for oocyte donors was 35 years (67.9%). In contrast, upper age limits for sperm donors were more dispersed, with 40 years being the most common age at response to intrauterine insemination (35.6%) and in vitro fertilization (35.9%). The most accepted indications were hypergonadotropic hypogonadism for oocyte donation (87.5%) and failure to retrieve sperm via micro‐testicular sperm extraction for donor sperm treatment (97.3%). Most facilities considered psychosocial support necessary. Conclusions: This study provides a comprehensive overview of institutional perspectives on third‐party ART in Japan. Although facilities showed substantial agreement on core principles, their views on specific eligibility and operational criteria varied.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (25FB2001)
- Japan Society for the Promotion of Science (25K20078)
This publication has 15 references indexed in Scilit:
- Assisted Reproductive Technology in Japan: A Summary Report for 2023 by the Committee on Professional Scientific Conduct and Clinical Ethics of the Japan Society of Obstetrics and GynecologyReproductive Medicine and Biology, 2025
- Assisted reproduction with advancing paternal and maternal age: an Ethics Committee opinionFertility and Sterility, 2025
- Survey on ART and IUI: legislation, regulation, funding, and registries in European countries—an updateHuman Reproduction, 2024
- Gamete and embryo donation guidanceFertility and Sterility, 2024
- Psychological adjustment in disclosing and non-disclosing heterosexual-couple families following conception with oocytes or spermatozoa from identity-release donorsReproductive BioMedicine Online, 2022
- Access to fertility treatment irrespective of marital status, sexual orientation, or gender identity: an Ethics Committee opinionFertility and Sterility, 2021
- The use of expanded carrier screening of gamete donorsHuman Reproduction, 2021
- Testing and interpreting measures of ovarian reserve: a committee opinionFertility and Sterility, 2020
- Repetitive oocyte donation: a committee opinionFertility and Sterility, 2020
- III. Gamete and embryo donationHuman Reproduction, 2002